XOMAP Q3 2021 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$940,000+68.8% YoY

Gross Profit

$910,00096.8% margin

Operating Income

-$3M-355.9% margin

Net Income

-$4M-471.9% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

+4.3%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$10M

Stock-Based Comp.

$779,000

Balance Sheet

Total Assets

$131M

Total Liabilities

$19M

Stockholders' Equity

$112M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$940,000	$557,000	+68.8%
Gross Profit	$910,000	$523,000	+74.0%
Operating Income	-$3M	-$3M	-24.4%
Net Income	-$4M	-$1M	-311.9%